On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing ...
Please provide your email address to receive an email when new articles are posted on . Familial hypercholesterolemia is underdiagnosed and undertreated. A novel machine learning algorithm identified ...
TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ...
DEAR DR. ROACH: I am a 69-year-old woman who was diagnosed with familial hypercholesterolemia (FH). I used statins for over a decade but developed vulvar lichen sclerosus (LS), which only went away ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
ANAHEIM, Calif.--(BUSINESS WIRE)--The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of patients in its CASCADE FH ® Registry showing that ...
with familial hyper cholesterolemia familial means the disease runs in families so it has a genetic predisposition hyper means excess and lastly cholesterolemia refers to the level of cholesterol in ...
FDA expands Juxtapid approval for pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia to reduce plasma LDL-C levels.
September 24 celebrates Familial Hypercholesterolemia Awareness Day, which recognizes the importance of screening measures, education, and advocacy in a lesser-known, underdiagnosed cardiovascular ...
Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...
Evkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (FDA) and European Commission (EC) to treat an ultrarare, inherited form of high cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results